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We describe the clinical characterization, molecular analyses, and genetic mapping of a distinct genetic condition
characterized by craniosynostosis, delayed closure of the fontanel, cranial defects, clavicular hypoplasia, anal and
genitourinary malformations, and skin eruption. We have identified seven patients with this phenotype in four
families from different geographic regions and ethnic backgrounds. This is an autosomal recessive condition that
brings together apparently opposing pathophysiologic and developmental processes, including accelerated suture
closure and delayed ossification. Selected candidate genes—including RUNX2, CBFB, MSX2, ALX4, TWIST1, and
RECQL4—were screened for mutations, by direct sequencing of their coding regions, and for microdeletions, by
fluorescent in situ hybridization. No mutations or microdeletions were detected in any of the genes analyzed. A
genomewide screen yielded the maximum estimated LOD score of +2.38 for markers D22S283 and D22S274 on
chromosome 22q12-q13. We hypothesize that the gene defect in this condition causes novel context-dependent
dysregulation of multiple signaling pathways, including RUNX2, during osteoblast differentiation and craniofacial
morphogenesis.
In this study, we present the clinical characterization of
a distinct genetic condition that associates a severe form
of craniofacial dysplasia with genitourinary and skin
manifestations. We have used the acronym “CDAGS”
because it summarizes the most prominent features of
this disorder: “C” stands for craniosynostosis and cla-
vicular hypoplasia; “D,” for delayed closure of the fon-
tanel, cranial defects, and, in some patients, deafness;
“A,” for anal anomalies, including anterior placement
of the anus and imperforate anus; “G,” for genitourinary
malformations; and “S,” for skin eruption, which, in some
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of the patients, has been classified as porokeratosis. To
date, we have identified seven patients, in four families,
with the CDAGS phenotype.
The craniofacial component of CDAGS overlaps with
some of the features seen in cleidocranial dysplasia (CCD
[MIM 119600]), an autosomal dominant disorder char-
acterized by hypoplastic or absent clavicles, delayed clo-
sure of the cranial sutures and fontanels, dental anomalies,
and delayed skeletal development (Cooper et al. 2001).
Most cases of CCD are caused by mutations in RUNX2,
located on chromosome 6p21 (Lee et al. 1997; Mundlos
et al. 1997). RUNX2 encodes a runt domain transcrip-
tional factor RUNX2, which is required for both osteo-
blast differentiation and chondrocyte maturation (Zhou
et al. 1999, Zheng et al. 2003). Other conditions, such
as Yunis-Varon syndrome (MIM 216340) and Crane-
Heise syndrome (MIM 218090) share some phenotypic
characteristics with CCD, such as cranial dysostosis and
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Figure 1 A, Craniofacial features of CDAGS syndrome in the index patient at age 8 mo. Note the brachycephaly, frontal bossing, and
sparse eyelashes and eyebrows. The skin lesions on the patient’s face became markedly hyperpigmented at age 2 mo. B, Skin lesions on arms
and legs, which occur in a psoriasis-like distribution and affect the margins of the earlobes. Color pictures are included in appendix A (online
only). C, Posterolateral and anterolateral views of the 3D reconstruction of the CT of the head of the index patient at age 1 mo. Notice the
wide metopic suture extending to the nasal bridge, wide-open anterior and posterior fontanels, bilateral PF, and coronal synostosis (arrows).
clavicular hypoplasia; the fact that similar skeletal ele-
ments are affected in some of these conditions suggests
that they may result from mutations in genes that affect
the context-dependent action of RUNX2 on its down-
stream targets. Moreover, phenocopies of this clinical
feature may help to identify in vivo regulators of the
RUNX2 transcriptional network.
Our index patient is an African American female who
was referred for evaluation because of imperforate anus
and dysmorphic features. Initial assessment on day 1 of
life demonstrated midface hypoplasia, frontal bossing,
large anterior and posterior fontanels, open metopic su-
ture extending down to the nasal bridge, and wide-open
sagittal suture. Her clavicles were hypoplastic, and her
shoulders could be brought together at the midline. Her
genitalia appeared normal, but she had an imperforate
anus with rectoperineal fistula. Skin examination revealed
multiple papules over the brow and posterior hairline
as well as hyperkeratotic areas on her scalp. She had
very sparse hair, eyelashes, and eyebrows, which did not
improve with age (fig. 1A). Her prenatal history was nega-
tive for complications, maternal illness, and toxic ex-
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Figure 2 Pedigrees of the four families with CDAGS that have
been identified to date. Three families have more than one affected
individual, and two have an affected male and female. In all families,
there was no history of previous affected individuals, and all families
deny consanguinity.
posure. The family history is negative for consanguinity,
malformations, and fetal demise.
The patient’s skin lesions progressed, and, at age 4 mo,
they were present on the face and extremities as papules
and ruptured vesicles, with an erythematous indurated
border in a psoriasis-like distribution (fig. 1B). A skin
biopsy of a lesion on the right forearm was performed.
Gross inspection revealed heavily pigmented skin with
a surface plaque. Microscopic examination showed hy-
perkeratosis, acanthosis, and an intraepithelial pustule
containing mixed inflammatory cells. There was focal
disruption of the dermal-epidermal junction, and some
of the keratinocytes had cytoplasmatic granules con-
taining melanin. Skin biopsy of a lesion on the left thigh
showed a lichenoid infiltrate composed of lymphocytes,
neutrophils, and occasional eosinophils, with numerous
colloid bodies within the epithelium.
A chest X-ray showed absence of the medial aspects
of the clavicles, kyphosis of the thoracic spine, and short
ribs. The scapula and vertebral bodies appeared normal.
A skeletal survey also revealed poor ossification of the
parietal bones and apparent hypoplasia of the sphenoid
bone and of the midfacial bones involving the nasion
and the maxillary bones. The remainder of the skeleton
was within normal limits. A CT scan of the head showed
a brachycephalic skull with bilateral coronal synosto-
sis, wide-open metopic suture, and bilateral parietal fo-
ramina (PF) (fig. 1C). A magnetic resonance image (MRI)
of the brain showed no structural abnormalities and a
myelination pattern normal for age. Spinal and renal
ultrasound results were normal. A hearing screen iden-
tified unilateral sensorineural hearing loss. Chromo-
some analysis by G-banding revealed a normal 46,XX
karyotype.
We have identified and examined six additional pa-
tients from a total of four pedigrees, with similar find-
ings. The families come from different geographic regions
and ethnic backgrounds (fig. 2). Three of the families have
two affected individuals, and two of those families have
both male and female affected siblings. For all individu-
als evaluated, the family history was negative for similar
defects. The pattern of transmission observed is consis-
tent with an autosomal recessive Mendelian trait.
Family 2 is of Mexican American descent. The clinical
and radiological findings for the two affected individuals
in this family show striking similarities to those of the
index patient, with severe skin rash, imperforate anus,
and cranial defects, including bilateral PF and coronal
synostosis (fig. 3). Biopsy of skin lesions on the arms
showed histological findings of porokeratosis. In addition
to these findings, the older affected individual in this
family has profound bilateral sensorineural hearing loss
and severe developmental delay. For detailed clinical in-
formation about the patients, see appendix A (online
only).
Family 3 is of Japanese descent and comprises two
affected siblings, a boy and a girl. These patients were
originally described by Fukuda et al. (1981) as having
an atypical form of CCD, characterized by clavicular hy-
poplasia, wide-open sutures and fontanel, anal atresia,
and skin lesions described as erythematous plaques with
erosion. Watanabe et al. (1996) published another article
about these patients and described the skin lesions as a
form of psoriasiform erythrokeratodermia.
Family 4 is white and is of Irish descent. Judge et al.
(1990) published a study describing the older individual
as having porokeratosis and craniosynostosis. Flanagan
et al. (1998) described this patient and his brother as
having familial craniosynostosis, anal anomalies, and
porokeratosis and used the acronym “CAP” (MIM
603116) for the constellation of findings. Both individuals
in this family presented with brachycephaly, wide-open
anterior and posterior fontanels, and complete coronal
synostosis. Flanagan et al. (1998) tested the patients of
this family for mutations associated with craniosynostosis
in the fibroblast growth-factor receptors 1, 2, and 3
(FGFR1, FGFR2, and FGFR3) and in the TWIST1 genes,
and no abnormalities were found (Flanagan et al. 1998).
Table 1 summarizes the clinical findings in the seven
patients identified to date. The most consistent features
of CDAGS syndrome are coronal synostosis, wide-open
anterior and posterior fontanel with PF, underdeveloped
eyebrows and eyelashes, imperforate anus, and skin le-
sions. In two of the families, the histological findings of
the skin biopsy were compatible with a diagnosis of poro-
keratosis. Additional features present in some but not
all of the patients include hypoplastic clavicles, senso-
rineural hearing loss, developmental delay, cleft palate,
and hypospadias. The four patients with developmental
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Figure 3 Clinical and radiological findings in family 2, showing striking similarities with the index patient. Notice the characteristic skin
rash on the 3-year-old female’s face (A) and extremities (B), whereas, in her 11-year-old brother, although there is persistence of hyperkeratotic
plaques on the elbows and knees (C), facial skin lesions have improved significantly (D). Both patients have dysmorphic features and sparse
eyebrows and eyelashes. Color pictures are included in appendix A (online only). Anteroposterior and lateral views of the 3D reconstruction
of the CT of the head in the female (panels E and F) and male (panels G and H) at age 1 mo demonstrate the characteristic cranial defects.
delay have some degree of hearing impairment, which
may account for some of the deficits. However, these
patients have problems with speech and motor skills that
do not improve with therapy.
To identify the molecular basis of the disorder, we
initially undertook a candidate-gene approach. Figure 4
summarizes the genes that were considered on the basis
of the phenotypic characteristics. Because the phenotype
shares multiple characteristics with CCD, RUNX2 and
its coactivator, the core binding factor beta (CBFB) were
attractive candidates (Kundu et al. 2002; Yoshida et al.
2002). PF are symmetric defects of parietal bone ossifica-
tion that can be seen as an isolated defect or as part of
different clinical syndromes. When the defects are large,
they may be the main manifestation of the condition
known as “parietal foramina” (PFM [MIM 168500]). PF
have been described in association with CCD in two
families whose affected members have hypoplastic clavi-
cles and delayed closure of the fontanel but no additional
findings (PF with CCD [MIM 168550]) (Golabi et al.
1984). Heterozygous loss-of-function mutations in MSX2
have been described in three unrelated families with PF
(Wilkie et al. 2000). Moreover, a mouse model with a
targeted disruption of Msx2 showed ossification defects
in the frontal bone as well as developmental defects in
three ectodermal organs, including teeth, hair follicles,
and mammary glands (Satokata et al. 2000). PF are also
a feature of Potocki-Shaffer syndrome (MIM 601224),
which is caused by a proximal 11p deletion that includes
the ALX4 gene. Isolated mutations in ALX4 have also
been described in families segregating PF (Wuyts et al.
2000; Mavrogiannis et al. 2001). Both MSX2 and ALX4
have been shown to interact with RUNX2, and, together,
these proteins participate in skull-vault differentiation
(Hermanns and Lee 2001; Shirakabe et al. 2001; An-
tonopoulou et al. 2004).
In contrast to these developmental defects that result
from loss of normal function, the premature fusion of
the sutures of the cranium has been shown to result from
molecular mechanisms that lead to an excess of signal.
Activating mutations in FGFR1, FGFR2, and FGFR3
cause seven different clinical syndromes that are charac-
terized by craniosynostosis and variable degrees of skele-
tal abnormalities. In addition, a missense gain-of-func-
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Figure 4 Venn diagram summarizing the features that charac-
terize CDAGS syndrome and its potential molecular mechanism. GU
p genitourinary.
Table 1
Clinical Summary of the Most Prominent Features of CDAGS Syndrome in the Four Families Analyzed
CHARACTERISTIC
FINDING IN PATIENT
1-II-1 2-II-1 2-II-5 3-II-1 3-II-2 4-II-1 4-II-3
Sex F M F F M M M
Coronal craniosynostosis    ND ND  
Other craniosynostosis  Lambdoida Lambdoid ND ND Sagittal Sagittal
Wide-open fontanels      ND 
PF      ND ND
Hearing loss Unilateral Sensorineural  ND Mixed b b
Developmental delayc  Severe Mild Severe Moderated  
Hypoplastic clavicles       ND
Imperforate anus      /e 
Hypospadias       /f
Urethrorectal fistula       
Skin lesionsg      h h
Porokeratosis on biopsy   ND    ND
NOTE.—Plus sign () p present; double plus sign () p severe; minus sign () p absent; / p partial
related finding; ND p not documented.
a Squamosal and lambdoid synostosis and cleft palate.
b Normal hearing per report, but not formally tested.
c The developmental delay present in some individuals is variable and affects both motor and language development.
d .IQ ! 40
e Anteriorly placed anus.
f Bifid scrotum.
g The eruption is composed of hyperkeratotic papules and plaques and has a reticulate pattern on the face.
h Patient exhibited a Koebner phenomenon.
tion mutation in MSX2 (P148H), which increases the
DNA-binding ability of the protein, has been found to
cause Boston-type craniosynostosis (Ma et al. 1996).
Transgenic mice overexpressing wild-type Msx2 in the
skull develop craniosynostosis and ectopic bone forma-
tion, suggesting a dominant positive effect of this protein
in suture closure (Liu et al. 1995). Another important
player in craniofacial development and craniosynostosis
is TWIST1. Deletions and point mutations that result in
loss of function of TWIST1 have been found in patients
with Saethre-Chotzen syndrome (MIM 101400), which
is characterized by craniosynostosis, delayed closure of
fontanels, and hand anomalies (Johnson et al. 1998).
TWIST1 has been shown to interact with RUNX2 and
to repress its function (Yousfi et al. 2002; Bialek et al.
2004).
The dermatological manifestations of CDAGS syn-
drome are a striking and consistent finding in the families
studied. The histological findings on biopsy of two fami-
lies were consistent with a diagnosis of porokeratosis, a
clinically heterogeneous disorder of keratinization (Hiv-
nor et al. 2004). The genetics of this group of disorders
is still poorly understood, although there are reports of
multiple pedigrees that show autosomal dominant trans-
mission, and several loci have been suggested through
linkage analysis. Mutations in the gene SSH1 (MIM
606778) on chromosome 12q24 were recently described
in Chinese families with disseminated superficial actinic
porokeratosis (Zhang et al. 2004). A common mecha-
nism linking the skin findings and coronal synostosis in
our patients could be the deregulation of MSX2 ex-
pression. In addition to its expression during cranial de-
velopment, MSX2 is expressed in the matrix epithelial
cells of hair follicles and the nail bed (Reginelli et al.
1995). In addition to craniosynostosis, transgenic mice
overexpressing Msx2 showed thickened skin with hyper-
keratosis, desquamation, and flakiness, with fewer hairs
(Jiang et al. 1999).
Genitourinary and anal abnormalities are another con-
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Figure 5 Multipoint linkage analysis with polymorphic markers
throughout the genome demonstrated the maximum expected LOD
score of 2.38 for markers D22S283 and D22S274 on the long arm
of chromosome 22 (22q12-q13).
sistent finding in patients with CDAGS. Imperforate anus
can be found as an isolated defect or can be part of a
syndrome or a sequence. Multiple genes have been stud-
ied as candidates in anorectal malformation syndromes,
and there are several reports of families segregating this
feature as autosomal recessive and X-linked traits (Villa-
vicencio et al. 2000; Mo et al. 2001). The strongest evi-
dence for genes responsible for imperforate anus is de-
rived from animal models and points toward genes in-
volved in the sonic hedgehog pathway (Kim et al. 2001;
Mo et al. 2001). Some syndromes, such as Baller-Gerold
syndrome (MIM 218600) and Antley-Bixler syndrome
(MIM 207410), demonstrate an association between cra-
niosynostosis and genitourinary/anal malformations. Al-
though the etiology of these syndromes has not been
completely elucidated, some patients with Antley-Bixler
syndrome carry mutations in the P450 oxidoreductase
gene (POR [MIM 124015]) that result in abnormal
steroidogenesis (Adachi et al. 2004; Fukami et al. 2005).
Patients with features of Baller-Gerold syndrome have
been found to have mutations in TWIST1 (Seto et al.
2001) as well as in the DNA helicase RECQL4 (Van
Maldergem et al. 1992, 2004). Interestingly, mutations
in RECQL4 result in a spectrum of autosomal recessive
disorders that also includes Rothmund-Thomson syn-
drome (RTS [MIM 268400]) and RAPADILINO syn-
drome (MIM 266280) (Siitonen et al. 2003). RTS is
characterized by short stature, cataracts, a predisposi-
tion to tumors, and a poikilodermatous rash that partly
resembles the one seen in our patients (Megarbane et al.
2000; Wang et al. 2001).
All seven affected individuals and their first-degree
relatives were enrolled in a research program approved
by the Baylor College of Medicine institutional review
board, and appropriate informed consent was obtained.
We isolated genomic DNA of the two patients who were
first ascertained, individuals 1-II-1 and 3-II-2, for can-
didate-gene studies. Sequence analysis of all eight exons
and the promoter of RUNX2 was performed as de-
scribed elsewhere (Zhou et al. 1999). Similarly, the cod-
ing regions of the genes CBFB, MSX2, TWIST1, and
RECQL4 were amplified by PCR and were analyzed by
direct sequencing. No mutations were found in the cod-
ing regions of any of these genes. Because of the pos-
sibility that this syndrome may be caused by a contigu-
ous gene deletion, we performed FISH with probes speci-
fic for RUNX2, CBFB, and ALX4. All FISH analyses
showed a normal hybridization pattern, consistent with
the presence of both alleles in each case (data not
shown).
On the basis of the pattern of inheritance, we assumed
an autosomal recessive mode of transmission and per-
formed simulation analysis to estimate the power to de-
tect linkage. Assuming full penetrance, an allele frequency
of 0.001, and no locus heterogeneity, we estimated the
maximum LOD score to be 2.38 with a mean (SE)
of 1.66 (0.03). We isolated DNA from all affected
patients and first-degree relatives of the four families.
Using Linkage Mapping Set v2.5-MD10 (Applied Bio-
systems), we performed a genomewide screen with 400
markers at an average resolution of 10 cM. We per-
formed parametric two-point linkage analysis, using the
Fastlink software (National Center for Biotechnology
Information), to locate the genomic region harboring the
gene responsible for the phenotype, and we used Allegro
for multipoint analysis and fine mapping. Analysis of
the genotype data showed maximum estimated LOD
score of 2.38 for markers D22S283 and D22S274 on
chromosome 22q12-q13 (fig. 5 and table B1 [online
only]). Haplotype analysis allowed us to narrow the re-
gion of interest to a 34-cM interval between D22S1163
and D22S1170. These results suggest that the disease
gene lies in this region on 22q12-q13.
Chromosome region 22q12-q13 spans 20 Mb and con-
tains 1100 genes. There are several reports of patients
with structural abnormalities involving this region, but
none of them provides clues as to the possible gene re-
sponsible for CDAGS syndrome. Deletions spanning the
segment 22q12-qter may result in developmental delay
but only minor anomalies (Watt et al. 1985; Kirshen-
baum et al. 1988). Isolated deletions of 22q13 have com-
mon features that include accelerated growth, develop-
mental delay, hearing loss, delayed myelination, hypo-
tonia, and minor dysmorphisms (Lindquist et al. 2005).
Duplication of 22q12-qter has been associated with in-
trauterine growth restriction (IUGR), cleft palate, mild
hearing loss, imperforate anus, and talipes (Mirza et al.
2000), and an isolated duplication of 22q13 resulted in
true hermaphroditism in a patient with IUGR and am-
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biguous genitalia that is due to an unbalanced translo-
cation (Aleck et al. 1999).
In this study, we present a complete clinical charac-
terization of CDAGS syndrome, a distinct genetic condi-
tion that associates craniofacial anomalies, clavicular hy-
poplasia, anal and genital abnormalities, and severe skin
eruption. The clinical features of these patients point to
the apparently opposing biological processes of delayed
ossification and accelerated suture closure. It is well
known that the function of the transcription factor
RUNX2 is context dependent and is regulated by mul-
tiple coactivators and repressors. Whereas this transcrip-
tion factor is essential for osteoblast cell-fate commit-
ment, it is also a major determinant of chondrocyte
maturation. Hence, it serves critical functions during
both endochondral and intramembranous ossification.
Interestingly, genes that have been implicated in cranio-
synostosis, such as TWIST and MSX2, have been re-
ported to directly regulate RUNX2 activity both in cell
studies and in vivo. We hypothesize that the gene defect
responsible for CDAGS syndrome causes novel context-
dependent dysregulation of multiple signaling pathways,
including RUNX2, during osteoblast differentiation and
craniofacial morphogenesis. It is possible that patients
with this constellation of findings have mutations in a
central regulatory factor that specifies the balance of
RUNX2 activity in these diverse tissues. At the same
time, this factor must also serve a function independent
of RUNX2 in tissues such as skin and in the genito-
urinary system, where RUNX2 is not expressed.
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